XML 45 R31.htm IDEA: XBRL DOCUMENT v3.25.3

Segment Information (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Schedule of Net Sales and Operating Profit by Segment

The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:

			Three Months Ended September 30, 2025
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	999					$	398					$	401					$	10					$	190
Latin America			1,178						541						303						(2)						337
Europe			801						300						285						7						209
Asia Pacific			714						270						264						(8)						188
Africa/Eurasia			297						118						106						4						68
Total Oral, Personal and Home Care			3,989																								992
Pet Nutrition			1,142						457						427						2						255
Reconciliation with Total Company Operating Profit
Corporate																											(189)
Total			$	5,131																							$	1,059

Note: Table may not sum due to rounding.

(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

			Nine Months Ended September 30, 2025
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	3,024					$	1,178					$	1,233					$	33					$	580
Latin America			3,528						1,555						936						(15)						1,052
Europe			2,228						832						811						20						566
Asia Pacific			2,092						796						746						(22)						573
Africa/Eurasia			863						339						323						12						190
Total Oral, Personal and Home Care			11,735																								2,961
Pet Nutrition			3,417						1,356						1,280						4						778
Reconciliation with Total Company Operating Profit
Corporate																											(523)
Total			$	15,152																							$	3,214

Note: Table may not sum due to rounding.

(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

			Three months ended September 30, 2024
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	1,004					$	381					$	409					$	8					$	206
Latin America			1,156						459						325						7						365
Europe			744						275						280						8						181
Asia Pacific			725						269						264						(8)						199
Africa/Eurasia			278						109						99						5						65
Total Oral, Personal and Home Care			3,907																								1,016
Pet Nutrition			1,126						463						406						(1)						258
Reconciliation with Total Company Operating Profit
Corporate																											(208)
Total			$	5,033																							$	1,065

Note: Table may not sum due to rounding.

(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

			Nine Months Ended September 30, 2024
			Net sales						Cost of Sales						Selling, general and administrative expenses						Other (income) expense, net (1)						Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America			$	3,076					$	1,166					$	1,254					$	23					$	633
Latin America			3,676						1,464						1,023						2						1,187
Europe			2,102						801						777						22						502
Asia Pacific			2,133						814						739						(21)						602
Africa/Eurasia			827						319						301						12						195
Total Oral, Personal and Home Care			11,814																								3,119
Pet Nutrition			3,342						1,404						1,239						9						691
Reconciliation with Total Company Operating Profit
Corporate																											(605)
Total			$	15,156																							$	3,205

Note: Table may not sum due to rounding.

(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:

			Three Months Ended												Nine Months Ended
			September 30,												September 30,
			2025						2024						2025						2024
Net sales
Oral Care			44		%				44		%				44		%				43		%
Personal Care			18		%				18		%				17		%				18		%
Home Care			16		%				16		%				16		%				17		%
Pet Nutrition			22		%				22		%				23		%				22		%
Total Net sales			100		%				100		%				100		%				100		%

Capital expenditures and depreciation and amortization expense by segment were:

			Three Months Ended												Nine Months Ended
			September 30,												September 30,
			2025						2024						2025						2024
Capital expenditures
Oral, Personal and Home Care
North America			$	18					$	9					$	48					$	30
Latin America			46						34						96						80
Europe			18						13						38						33
Asia Pacific			17						22						49						41
Africa/Eurasia			4						3						8						6
Total Oral, Personal and Home Care			103						81						239						190
Pet Nutrition			21						24						64						108
Corporate			31						29						84						79
Total Capital expenditures			$	155					$	134					$	387					$	377

			Three Months Ended												Nine Months Ended
			September 30,												September 30,
			2025						2024						2025						2024
Depreciation and amortization
Oral, Personal and Home Care
North America			$	32					$	30					$	92					$	93
Latin America			27						24						78						77
Europe			16						17						48						49
Asia Pacific			19						20						59						60
Africa/Eurasia			3						2						7						6
Total Oral, Personal and Home Care			97						93						284						285
Pet Nutrition			35						33						98						100
Corporate			26						24						75						72
Total Depreciation and amortization			$	158					$	150					$	457					$	457

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration